Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-016814
Filing Date
2023-05-09
Accepted
2023-05-09 16:08:24
Documents
72
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-20230331.htm   iXBRL 10-Q 1151499
2 EX-31.1 prtkex-311x331202310xq.htm EX-31.1 10000
3 EX-31.2 prtkex-312x331202310xq.htm EX-31.2 9985
4 EX-32.1 prtkex-321x331202310xq.htm EX-32.1 5176
5 EX-32.2 prtkex-322x331202310xq.htm EX-32.2 5187
  Complete submission text file 0001628280-23-016814.txt   6430583

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prtk-20230331.xsd EX-101.SCH 64841
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prtk-20230331_cal.xml EX-101.CAL 52715
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prtk-20230331_def.xml EX-101.DEF 284654
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prtk-20230331_lab.xml EX-101.LAB 670779
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prtk-20230331_pre.xml EX-101.PRE 406041
66 EXTRACTED XBRL INSTANCE DOCUMENT prtk-20230331_htm.xml XML 874154
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 23902005
SIC: 2834 Pharmaceutical Preparations